Transfection of cells using flow-through electroporation based on constant voltage

Nature Protocols

Volumn 6, Issue 8, 2011, Pages 1192-1208

  Geng, Tao ^a   Zhan, Yihong ^a   Wang, Jun ^a   Lu, Chang ^b  

^a PURDUE UNIVERSITY   (United States)

^b State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CHO CELL; CRICETULUS; ELECTROPORATION; EQUIPMENT DESIGN; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HAMSTER; INSTRUMENTATION; METABOLISM; METHODOLOGY; PLASMID;

ANIMALS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DNA; ELECTROPORATION; EQUIPMENT DESIGN; GENE TRANSFER TECHNIQUES; PLASMIDS; TRANSFECTION;

EID: 84555189660     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2011.360     Document Type: Article

References (46)

1. Blattman, J. N., Greenberg, P. D., Cancer immunotherapy: a treatment for the masses. Science 305, 200-205 (2004).
2. Kershaw, M. H., Teng, M. W., Smyth, M. J., Darcy, P. K., Supernatural T cells: genetic modification of T cells for cancer therapy. Nat. Rev. Immunol. 5, 928-940 (2005).
3. Gersbach, C. A., Phillips, J. E., Garcia, A. J., Genetic engineering for skeletal regenerative medicine. Annu. Rev. Biomed. Eng. 9, 87-119 (2007).
4. Kumar, S., Chanda, D., Ponnazhagan, S., Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther. 15, 711-715 (2008).
5. Wong, G. K., Chiu, A. T. Gene therapy, gene targeting and induced pluripotent stem cells: applications in monogenic disease treatment. Biotechnol. Adv. 29, 1-10 (2011).
6. Hacein-Bey-Abina, S., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-11. Science 302, 415-419 (2003).
7. Hacein-Bey-Abina, S., et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-11. J. Clin. Invest. 118, 3132-3142 (2008).
8. Yang, Y., et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411 (1994).
9. Knowles, M. R., et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333, 823-831 (1995).
10. Raper, S. E., et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148-158 (2003).
11. Miller, D. G., Rutledge, E. A., Russell, D. W., Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30, 147-148 (2002).
12. Nakai, H., et al. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79, 3606-3614 (2005).
13. Bell, P., et al. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol. Ther. 14, 34-44 (2006).
14. Donsante, A., et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317, 477 (2007).
15. Luo, D., Saltzman, W. M., Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33-37 (2000).
16. Segura, T., Shea, L. D., Materials for non-viral gene delivery. Annu. Rev. Mater. Res. 31, 25-46 (2001).
17. Montier, T., et al. Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol. 22, 586-592 (2004).
18. Fedorov, Y., et al. Different delivery methods different expression profiles. Nat. Methods 2, 241 (2005).
19. Chang, D. C., Chassy, B. M., Saunders, J. A., Sowers, A. E., (eds). Guide to Electroporation and Electrofusion (Academic Press, 1992).
20. Neumann, E., Schaefer-Ridder, M., Wang, Y., Hofschneider, P. H., Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841-845 (1982).
21. Prausnitz, M. R., Bose, V. G., Langer, R., Weaver, J. C., Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA 90, 10504-10508 (1993).
22. Rols, M. P., et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat. Biotechnol. 16, 168-171 (1998).
23. Aihara, H., Miyazaki, J., Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870 (1998).
24. Weaver, J. C., Chizmadzhev, Y. A., Theory of electroporation: a review. Bioelectroch. Bioener. 41, 135-160 (1996).
25. Teissie, J., Golzio, M., Rols, M. P., Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of?) knowledge. Biochim. Biophys. Acta. 1724, 270-280 (2005).
26. Huang, Y., Rubinsky, B., Flow-through micro-electroporation chip for high efficiency single-cell genetic manipulation. Sens. Actuators A Phys. 104, 205-212 (2003).
27. Lu, H., Schmidt, M. A., Jensen, K. F., A microfluidic electroporation device for cell lysis. Lab. Chip 5, 23-29 (2005).
28. Fei, Z., et al. Gene transfection of mammalian cells using membrane sandwich electroporation. Anal. Chem. 79, 5719-5722 (2007).
29. Valero, A., et al. Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device. Lab. Chip 8, 62-67 (2008).
30. Marc, P. J., Sims, C. E., Bachman, M., Li, G. P., Allbritton, N. L., Fast-lysis cell traps for chemical cytometry. Lab. Chip 8, 710-716 (2008).
31. Skelley, A. M., Kirak, O., Suh, H., Jaenisch, R., Voldman, J., Microfluidic control of cell pairing and fusion. Nat. Methods 6, 147-152 (2009).
32. Andre, F., Mir, L. M., DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther. 11 (Suppl 1) S33-S42 (2004).
33. Tekle, E., Astumian, R. D., Chock, P. B., Selective and asymmetric molecular transport across electroporated cell membranes. Proc. Natl. Acad. Sci. USA 91, 11512-11516 (1994).
34. Golzio, M., Teissie, J., Rols, M. P., Direct visualization at the single-cell level of electrically mediated gene delivery. Proc. Natl. Acad. Sci. USA 99, 1292-1297 (2002).
35. Geng, T., et al. Flow-through electroporation based on constant voltage for large-volume transfection of cells. J. Control Release 144, 91-100 (2010).
36. Wang, J., Zhan, Y., Ugaz, V. M., Lu, C., Vortex-assisted DNA delivery. Lab. Chip 10, 2057-2061 (2010).
37. Cavazzana-Calvo, M., et al. Gene therapy of human severe combined immunodeficiency (SCID)-11 disease. Science 288, 669-672 (2000).
38. Morgan, R. A., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126-129 (2006).
39. Luo, D., Saltzman, W. M., Enhancement of transfection by physical concentration of DNA at the cell surface. Nat. Biotechnol. 18, 893-895 (2000).
40. Mueller-Hartmann, H., Method and circuit arrangement for treating biomaterial. US patent 2006/0094095 A1 (2006).
41. Riemen, G., et al. Buffer solution for electroporation and a method comprising the use of the same. US patent 2005/0064596 A1.
42. Muller-Hartmann, H., Habig, M., Container and device for generating electric fields in different chambers. US patent 2006/0087522 A1 (2006).
43. Kim, J. A., et al. A novel electroporation method using a capillary and wire-type electrode. Biosens. Bioelectron. 23, 1353-1360 (2008).
44. Li, L. H., et al. Highly efficient, large volume flow electroporation. Technol. Cancer Res. Treat. 1, 341-350 (2002).
45. Wang, H. Y., Lu, C., Electroporation of mammalian cells in a microfluidic channel with geometric variation. Anal. Chem. 78, 5158-5164 (2006).
46. Wang, H.Y., Lu, C., Microfluidic electroporation for delivery of small molecules and genes into cells using a common DC power supply. Biotechnol. Bioeng. 100, 579-586 (2008)